RESUMO
Tradicionalmente se ha definido la respuesta broncodilatadora (RB) positiva como una mejoría ≥ de 12 % del VEF1. En el año 2022 se publica una Guía sobre la interpretación de función la pulmonar de la Sociedad Americana de Tórax y la Sociedad Europea de Enfermedades Respiratorias, donde se propone que la RB debe expresarse como el cambio porcentual del VEF1 en relación con el VEF1 predicho y que un cambio ≥ 10 % indica una RB positiva. Las sociedades científicas en Chile están evaluando estas recomendaciones para decidir su adecuada implementación en pediatría.
Traditionally, a positive bronchodilator (BR) response has been defined as a ≥ 12% improvement in FEV1. In the year 2022, a Guide on the interpretation of pulmonary function of the American Thoracic Society and the European Society of Respiratory Diseases was published, where it was proposed that BR should be expressed as the percent change in FEV1 relative to predicted FEV1 and that a change ≥ 10% indicates a positive BR. Scientific societies in Chile are evaluating these recommendations to decide their proper implementation in pediatrics.
Assuntos
Humanos , Criança , Doenças Respiratórias/fisiopatologia , Espirometria , Broncodilatadores/farmacologia , Volume Expiratório ForçadoRESUMO
La Oscilometría de Impulso (IOS) es una técnica no invasiva que evalúa las propiedades mecánicas de todo el sistema respiratorio durante la respiración tranquila. Mide la impedancia total del sistema respiratorio, evaluando la resistencia total de la vía aérea, la resistencia de la vía aérea alta y las propiedades elásticas del pulmón. Detecta el compromiso de la vía aérea periférica en forma muy precoz, antes que la espirometría, y es útil en niños pequeños porque no requiere maniobras de espiración forzada. Permite evaluar la respuesta broncodilatadora y broncoconstrictora a través de pruebas de provocación bronquial para el diagnóstico de hiperreactividad bronquial. La IOS tiene un rol en la evaluación temprana y seguimiento de la función pulmonar en niños con enfermedades respiratorias crónicas, principalmente asma bronquial, displasia broncopulmonar y fibrosis quística. Este artículo revisa los aspectos fisiológicos, técnicos y aplicación clínica de la IOS, considerando las últimas recomendaciones para la estandarización del examen y las limitaciones que dificultan su interpretación .
Impulse Oscillometry (IOS) is a non-invasive technique that assesses the mechanical properties of the entire respiratory system during quiet breathing. It measures the total impedance of the respiratory system by evaluating total airway resistance, upper airway resistance, and elastic properties of the lung. It detects peripheral airway compromise very early, before spirometry, and is useful in young children because it does not require forced expiration maneuvers. It allows evaluating the bronchodilator and bronchoconstrictor response through bronchial provocation tests for the diagnosis of bronchial hyperreactivity. The IOS has a role in the early evaluation and monitoring of lung function in children with chronic respiratory diseases, mainly bronchial asthma, bronchopulmonary dysplasia and cystic fibrosis. This article reviews the physiological, technical, and clinical application aspects, considering the latest recommendations for the standardization of the test and the limitations that hinder its interpretation.
Assuntos
Humanos , Criança , Oscilometria/métodos , Testes de Função Respiratória/métodos , Doenças Respiratórias/fisiopatologia , Fenômenos Fisiológicos Respiratórios , Doenças Respiratórias/diagnóstico , Resistência das Vias Respiratórias/fisiologiaRESUMO
Resumen La prueba de velocidad de marcha en 4 metros (T4M) es considerada sustituto de la caminata en 6 min (TC6M) en EPOC. Sin embargo, no ha sido bien investigada en otras enfermedades respiratorias. Durante un año estudiamos pacientes que concurrieron a nuestra Unidad para realizar el TC6M midiendo la velocidad alcanzada en 4 metros, 2 h previo a realizar el TC6M. De 162 pacientes 99 eran mujeres. La edad media fue de 65 años, peso de 73 kg, talla de 158 cm, IMC 29,4 kg/m2. 36% tenían fibrosis pulmonar idiopática, 17% EPOC, GOLD IV,11% EPOC, GOLD III, 12% apnea de sueño y 12% otras enfermedades. No hubo diferencia para los distintos diagnósticos en ambos tests. La distancia media en TC6Mfue 368,5 m la velocidad: 1,01 m/s en T4M.Hubo una correlación positiva significativa entre ambos test: alto rendimiento en T4M es equivalente a un alto rendimiento en el TC6M. Hubo correlación negativa con la edad y positiva con la estatura. Al año de seguimiento 16 pacientes habían fallecido, siendo estos los que habían obtenido los más bajos rendimientos en ambos tests (T4M: 0,69 m/s y 248,1 m en TC6M) La posibilidad de sobrevida cayó a 20% en aquellos individuos que alcanzaron una velocidad inferior a 0,69 m/s. Es posible sustituir el TC6M por el T4M en pacientes con diferentes patologías respiratoria, podemos predecir la muerte por cualquier causa si un sujeto camina a una velocidad ≤ 0,69 m/s, T4M es barato y fácil de realizar en atención primaria, sirviendo como evaluación de riesgo para referir a un centro más complejo.
4-Meter Gait Speed Test (4MGST) a frailty test, is considered a surrogate for the 6-Minute Walk Test (6MWT) in COPD. However, it has not been investigated in other respiratory conditions. Over a year, we studied patients attending our Unit for evaluation with 6MWT, measuring the speed they achieved walking 4 m, 2 h before performing 6MWT. 162 patients (99 women) were studied; series' mean values were: age 65 years-old; body weight, 73 kg; height, 158 cm and BMI, 29.4 kg/m2. 36% of them had idiopathic pulmonary fibrosis, 17% GOLD IV COPD, 11% GOLD III COPD, 12% pulmonary arterial hypertension, 12% obstructive apnea-hypopnea syndrome, and 12% other conditions. ANOVA showed no difference between diagnostic categories for both test. Average score in 6MWT was 368.5 m and 1.01 m/s in 4MGST. Pearson correlation coefficient revealed significant positive correlation between results of both tests: high score in 4MGST is equivalent to high score in 6MWT. There was negative correlation with age and positive correlation with height. At one year follow-up, 16 patients had died. They obtained significantly lower scores in both tests (4MGST: 0.69 m/s and 6MWT: 248.1 m) Survival chance fell to 20% for patients walking slower than 0.69 m/s. It is possible to replace TC6M with T4M in patients with different respiratory pathologies, we can predict death for any cause if a subject walked at ≤ speed at 0.69 m/s. T4M is cheap and easy to perform in primary care, serving as a risk assessment to refer to a more complex center.
Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Idoso , Atenção Primária à Saúde , Doenças Respiratórias/fisiopatologia , Teste de Caminhada , Doenças Respiratórias/mortalidade , Análise de Sobrevida , Doença Crônica , Doença Pulmonar Obstrutiva Crônica , Fibrose Pulmonar Idiopática , Velocidade de Caminhada , Hipertensão Arterial PulmonarRESUMO
BACKGROUND: Nonsteroidal anti-inflammatory drug-exacerbated respiratory disease (NERD) might benefit from aspirin desensitization (AD) as an alternative treatment to standard care. However, there is conflicting evidence regarding its role in bronchial symptoms and asthma exacerbations. OBJECTIVE: To analyze the clinical effects of AD in terms of lung function, systemic and inhaled steroid use, the frequency of acute asthma exacerbations, and adverse effects in patients with NERD and asthma. METHODOLOGY: We identified randomized clinical trials (RCTs) from PubMed, EMBASE, SCOPUS, and EBSCO. We also searched the RCT references for additional studies. Studies comparing AD to placebo in patients with a previous history of pulmonary symptoms triggered by ASA or other NSAIDs or with a positive provocation test to ASA were included. PRIMARY RESULTS: Five studies with 210 participants with NERD were included in this review. The study duration ranged from 3 to 6 months. Overall, the risk of bias across the included RCTs was low. We identified 3 studies evaluating lung function, 2 of which reported a significant improvement in FEV1 in the AD group after 6 months, while the other reported no difference among the treatments. Due to high heterogeneity, we did not pool the results. The remaining primary outcomes were reported only in a single study each, hindering their interpretation. Secondary outcomes revealed reduced symptom and medication scores in patients with AD. CONCLUSIONS: Due to the small number of studies included in this systematic review, conclusions should be made with caution. AD shows a trend towards improving lung function (FEV1) following 6 months of treatment, although no conclusions can be made regarding the use of corticosteroids or the frequency of acute exacerbations. AD appears to reduce both symptom and medication scores. Additional RCTs are needed to fully assess the efficacy of AD in reducing bronchial symptoms in patients with NERD.
Assuntos
Anti-Inflamatórios não Esteroides/efeitos adversos , Aspirina/efeitos adversos , Asma/tratamento farmacológico , Doenças Respiratórias/induzido quimicamente , Asma/fisiopatologia , Humanos , Doenças Respiratórias/fisiopatologiaRESUMO
La escoliosis es una enfermedad frecuente, de evolución variable según su etiología y edad de presentación. El diagnóstico y tratamiento oportuno permiten evitar el compromiso respiratorio, que es su principal complicación. La mayoría de los casos corresponden a escoliosis leves e idiopáticas, pero los casos severos, no idiopáticos o aquellos que presentan síntomas respiratorios, requieren de una evaluación oportuna por el equipo de enfermedades respiratorias. El objetivo de este trabajo es describir las alteraciones de la función pulmonar que se encuentran en niños con escoliosis y dar una orientación acerca de la evaluación y derivación de estos pacientes al neumólogo infantil. Con una evaluación oportuna se pueden iniciar planes de rehabilitación u otras intervenciones que permitan disminuir la morbimortalidad asociada a esta patología.
Scoliosis is a common disease with a variable evolution depending on its etiology and age of presentation. Timely diagnosis and treatment make it possible to avoid respiratory compromise, which is its main complication. Most cases correspond to mild and idiopathic scoliosis, but severe, non-idiopathic cases or those with respiratory symptoms require timely evaluation by the respiratory team. The objective of this work is to describe the pulmonary function alterations found in children with scoliosis and to provide guidance on the evaluation and referral of these patients to the pediatric pulmonologist. With a timely evaluation, rehabilitation plans or other interventions can be initiated to reduce the morbidity and mortality associated with this pathology.
Assuntos
Humanos , Criança , Testes de Função Respiratória , Doenças Respiratórias/etiologia , Doenças Respiratórias/fisiopatologia , Escoliose/complicações , Doenças Respiratórias/terapia , EspirometriaRESUMO
Las enfermedades infecciosas que comprometen el aparato respiratorio, generalmente son más graves en las gestantes y en las puérperas en comparación con las no embarazadas. Dentro de estas infecciones, se encuentran las producidas por agentes virales como la influenza estacional, pandémica y zoonótica, los coronavirus SARS, el MERS; y desde el año 2019 el SARS-CoV-2 causante de la actual pandemia COVID-19. Las noxas virales pueden ejercer un efecto deletéreo sobre el feto debido a respuesta inflamatoria vía cascada de citoquinas o daño directo a nivel de algunos tejidos. Los efectos del SARS-CoV-2 a nivel placentario, no están bien entendidos, los hallazgos histopatológicos incluyen alteraciones de la perfusión venosa materna y fetal y signos de inflamación placentaria en diferentes porcentajes. La placenta es un órgano altamente especializado que confiere una protección especial generando un ambiente protegido manteniendo un equilibrio de factores inmunes y bioquímicos que favorecen el desarrollo fetal. Su estructura funciona como una barrera protectora dificultando o impidiendo el paso de noxas al producto de la gestación. Diversos patógenos, incluyendo los virus pueden alterar los diferentes componentes celulares de la placenta. En la siguiente revisión describimos los más recientes hallazgos de la interacción con la placenta de diversos virus respiratorios y sus consecuencias en la salud materno fetal(AU)
Infectious diseases of the respiratory system generally present greater severity in women during pregnancy or puerperium, than in non-pregnant women. Among them, we find those produced by viral agents such as seasonal, pandemic and zoonotic influenza, SARS coronaviruses, MERS; and since 2019 the SARS-CoV-2, the cause of the current COVID-19 pandemic. Viral noxae can exert a deleterious effect on the fetus due to an inflammatory response via the cytokines cascade or direct damage at some tissues. The effects of SARS-CoV-2 on the placenta is not well understood, the histopathological findings include alterations of maternal and fetal perfusion and signs of placental inflammation in different degrees. The placenta is a highly specialized organ that confers a special protection by generating a protected environment maintaining a balance of immune and biochemical factors that favor the fetal development. Its structure works as a protective barrier, hindering or preventing the passage of noxae to the fetus. Several pathogens, including viruses, can alter different cellular components of the placenta. In the review, we describe the most recent findings of the interaction of various respiratory viruses with the placenta and their consequences on maternal and fetal health(AU)
Assuntos
Humanos , Feminino , Gravidez , Infecção Puerperal , Doenças Respiratórias/fisiopatologia , Doenças Transmissíveis , Gestantes , Vírus , Influenza Humana , COVID-19 , NoxasAssuntos
Poluição Ambiental/efeitos adversos , Material Particulado/efeitos adversos , Grupos Populacionais/estatística & dados numéricos , Doenças Respiratórias/epidemiologia , Doenças Respiratórias/etiologia , Incêndios Florestais/estatística & dados numéricos , Brasil , Bases de Dados Factuais , Monitoramento Ambiental/métodos , Feminino , Humanos , Incidência , Masculino , Doenças Respiratórias/fisiopatologia , Estudos Retrospectivos , Medição de Risco , Incêndios Florestais/prevenção & controleRESUMO
Non-steroidal anti-inflammatory drugs (NSAID) exacerbated respiratory disease (N-ERD) is a disease integrated by asthma, nasal polyps, and hypersensitivity to non-steroidal anti-inflammatory drugs (NSAID). Genetic association studies have explored single nucleotide polymorphisms (SNPs) in genes involved in theoretical pathophysiological mechanisms, but most of these lack replication of findings in second populations. Our objective was to evaluate the association of SNPs in candidate genomic regions described in Asian and European subjects with N-ERD in Mexican-mestizo patients. We designed a replicative study in two stages. We included 381 SNPs selected by fine mapping of associated genes in a microarray, which were tested in three groups: N-ERD (N), asthma (A), and control group (CG); by means of GoldenGate array, positive results by genetic models were validated in the second stage in another population through qPCR with the same methodology. In the allelic model, we identified 11 SNPs in N vs. CG comparison, and five in N vs. A and A vs. CG, respectively. By genetics models, all SNPs in PPARG, rs13239058 in TBXAS1, and rs1554286 and rs1800872 in IL10 were associated in both models. In the second stage, only rs1800872CC showed an association in the dominant model comparing N vs. GC, p = 0.004, OR = 0.44. In conclusion, rs1800872 in IL10 was the only associated with N-ERD in Mexican-mestizo patients.
Assuntos
Interleucina-10/genética , Doenças Respiratórias/tratamento farmacológico , Doenças Respiratórias/genética , Adulto , Alelos , Anti-Inflamatórios não Esteroides/farmacologia , Asma/tratamento farmacológico , Asma/fisiopatologia , Estudos de Casos e Controles , Feminino , Frequência do Gene/genética , Estudos de Associação Genética , Predisposição Genética para Doença/genética , Genótipo , Humanos , Interleucina-10/metabolismo , Masculino , México/epidemiologia , Pessoa de Meia-Idade , Polimorfismo de Nucleotídeo Único/genética , Síndrome do Desconforto Respiratório/tratamento farmacológico , Síndrome do Desconforto Respiratório/genética , Doenças Respiratórias/fisiopatologiaRESUMO
OBJECTIVE: To determine reference values of sniff nasal inspiratory pressure (SNIP) in healthy children. METHODS: This cross-sectional observational study included healthy children aged 6 to 11 years of both sexes. The volunteers underwent a pulmonary function test to rule out respiratory disorders. Respiratory muscle strength was measured using maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP), respectively, with MIP close to functional residual capacity (FRC) and residual volume, while MEP to total lung capacity. SNIP was performed through the nostril contralateral to the occlusion, close to FRC. Two 6-minute walk tests were performed to assess functional exercise capacity. RESULTS: The sample comprised 121 healthy children (62 girls); 54% presented body mass index (BMI) percentile less than 85th and 46% more than equal to 85th percentile, higher than expected. SNIP values were similar between sexes (91.1 ± 21.0 cmH2 O in girls and 87.7 ± 19.4 cmH2 O in boys; P = .36) as well as the means of lower limits of normal (56.88 cmH2 O for girls and 56.66 cmH2 O for boys). Girls presented SNIP measurements larger than those of the MIP of FRC (P < .0001), while boys presented similar mean values for both. We found a positive correlation between SNIP and BMI percentile (r = .25, P = .04) in girls, unlike boys, in whom no correlation was observed. CONCLUSIONS: SNIP reference values and mean lower limits of normal were defined for healthy children aged 6 to 11. BMI percentile seems to positively influence the inspiratory muscle strength measured by SNIP in girls only.
Assuntos
Pressões Respiratórias Máximas/normas , Cavidade Nasal , Índice de Massa Corporal , Criança , Estudos Transversais , Feminino , Capacidade Residual Funcional , Humanos , Masculino , Força Muscular/fisiologia , Pressão , Valores de Referência , Volume Residual , Testes de Função Respiratória , Músculos Respiratórios , Doenças Respiratórias/fisiopatologia , Capacidade Pulmonar TotalRESUMO
RESUMO As doenças respiratórias afetam milhões de pessoas, principalmente os idosos, e as mudanças climáticas estão entre os fatores predisponentes, interferindo na saúde dessa população. O objetivo deste estudo foi avaliar o pico de fluxo expiratório de idosos institucionalizados e não institucionalizados durante as quatro estações do ano. Estudo de coorte prospectivo com 67 idosos de ambos os sexos, residentes na cidade de Maringá (PR) e divididos em dois grupos: idosos institucionalizados (n=37) e idosos não institucionalizados (n=30). Os dados foram coletados durante um mês, uma vez por semana nas quatro estações do ano, totalizando 16 avaliações. O pico de fluxo expiratório foi avaliado com o equipamento peak flow meter. A comparação dos dois grupos de idosos foi feita por análise de variância de dois fatores utilizando o post-hoc de Bonferroni. A menor média de pico de fluxo expiratório para os idosos institucionalizados e não institucionalizados foi no verão (176,2±60,2 e 263,2±116,2), seguido pelo outono (193,4±59,5 e 287,5±118), inverno (215,3±82,5 e 291,5±08,4) e primavera (221,7±83,5 e 291,5±08,4). Conclui-se que o pico de fluxo expiratório de idosos varia de acordo com as estações do ano, porém os institucionalizados apresentam valores mais baixos. Os mais altos são encontrados na primavera, embora aquém do valor predito para os idosos de ambos os grupos.
RESUMEN Las enfermedades respiratorias afectan a millones de personas, especialmente a los ancianos, y el cambio climático es uno de los factores predisponentes que interfieren en la salud de esta población. El presente estudio tuvo como objetivo evaluar el flujo espiratorio máximo de ancianos institucionalizados y no institucionalizados durante las cuatro estaciones del año. Se realizó un estudio prospectivo de cohorte con 67 ancianos de ambos sexos que viven en la ciudad de Maringá (PR), los cuales se dividieron en dos grupos: ancianos institucionalizados (n=37) y ancianos no institucionalizados (n=30). Los datos se recolectaron durante un mes, una vez a la semana en las cuatro estaciones del año, y totalizó 16 evaluaciones. El flujo espiratorio máximo se evaluó con la herramienta peak flow meter. La comparación de los dos grupos de ancianos se realizó mediante el análisis de la varianza de dos factores utilizando el post hoc de Bonferroni. El promedio más bajo del flujo espiratorio máximo para los ancianos institucionalizados y no institucionalizados se registró en verano (176,2±60,2 y 263,2±116,2), seguido del otoño (193,4±59,5 y 287,5±118), invierno (215,3±82,5 y 291,5±08,4) y primavera (221,7±83,5 y 291,5±08,4). Se concluye que el flujo espiratorio máximo de los ancianos varía según las estaciones del año, sin embargo, los ancianos institucionalizados tienen los valores más bajos. Los más altos se encuentran en la primavera, aunque por debajo del valor previsto para los ancianos de ambos grupos.
ABSTRACT Respiratory diseases affect millions of people, especially the elderly, and climate change is among the predisposing factors interfering with the health of this population. This study aimed to evaluate the peak expiratory flow in institutionalized and noninstitutionalized elderly during the four seasons of the year. A prospective cohort study with 67 elderly men and women living in the city of Maringá, Paraná, Brazil, divided into two groups: institutionalized elderly (n=37) and noninstitutionalized elderly (n=30). The data were collected for one month, once a week in the four seasons of the year, totaling 16 evaluations. The peak expiratory flow was evaluated using the Peak-Flow Meter equipment. The two groups of elderly were compared by two-way analysis of variance using the Bonferroni post-hoc. The lowest mean peak expiratory flow for institutionalized and noninstitutionalized elderly was observed in the summer (176.2±60.2 and 263.2±116.2), followed by fall (193.4±59.5 and 287.5±118), winter (215.3±82.5 and 291.5±08.4), and spring (221.7±83.5 and 291.5±08.4). The conclusion was that the peak of expiratory flow of the elderly varies according to the seasons, but the institutionalized ones have lower values. The highest values are found in the spring, although below the value predicted for the elderly of both groups.
Assuntos
Humanos , Masculino , Feminino , Idoso , Idoso de 80 Anos ou mais , Mudança Climática , Fluxo Expiratório Forçado/fisiologia , Saúde do Idoso , Doenças Respiratórias/fisiopatologia , Estações do Ano , Envelhecimento/fisiologia , Estudos Prospectivos , Estudos de CoortesRESUMO
OBJECTIVE: To determine the frequency of spirometry in elderly people, by age group, at a pulmonary function clinic, to assess the quality of spirometry in the extremely elderly, and to determine whether chronological age influences the quality of spirometry. METHODS: This was a cross-sectional retrospective study evaluating information (spirometry findings and respiratory questionnaire results) obtained from the database of a pulmonary function clinic in the city of Aracaju, Brazil, for the period from January of 2012 to April of 2017. In the sample as a whole, we determined the total number of spirometry tests performed, and the frequency of the tests in individuals ≥ 60 years of age, ≥ 65 years of age, and by decade of age, from age 60 onward. In the extremely elderly, we evaluated the quality of spirometry using criteria of acceptability and reproducibility, as well as examining the variables that can influence that quality, such a cognitive deficit. RESULTS: The sample comprised a total of 4,126 spirometry tests. Of those, 961 (23.30%), 864 (20.94%), 102 (2.47%), and 26 (0.63%) were performed in individuals ≥ 60, ≥ 65, ≥ 86, and ≥ 90 years of age (defined as extreme old age), respectively. In the extremely elderly, the criteria for acceptability and reproducibility were met in 88% and 60% of the spirometry tests (95% CI: 75.26-100.00 and 40.80-79.20), respectively. The cognitive deficit had a negative effect on acceptability and reproducibility (p ≤ 0.015 and p ≤ 0.007, respectively). CONCLUSIONS: A significant number of elderly individuals undergo spirometry, especially at ≥ 85 years of age, and the majority of such individuals are able to perform the test in a satisfactory manner, despite their advanced age. However, a cognitive deficit could have a negative effect on the quality of spirometry.
Assuntos
Pulmão/fisiopatologia , Doenças Respiratórias/diagnóstico , Doenças Respiratórias/fisiopatologia , Espirometria/normas , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Envelhecimento/fisiologia , Disfunção Cognitiva , Comorbidade , Estudos Transversais , Feminino , Volume Expiratório Forçado/fisiologia , Humanos , Masculino , Pessoa de Meia-Idade , Pico do Fluxo Expiratório , Reprodutibilidade dos Testes , Doenças Respiratórias/psicologia , Estudos Retrospectivos , Fatores Sexuais , Espirometria/métodos , Espirometria/psicologia , Capacidade Vital/fisiologiaRESUMO
OBJECTIVE: To determine whether airway narrowing during obstructive events occurs predominantly at the retropalatal level and results from dynamic changes in the lateral pharyngeal walls and in tongue position. METHODS: We evaluated 11 patients with severe obstructive sleep apnea (OSA) and 7 healthy controls without OSA during wakefulness and during natural sleep (documented by full polysomnography). Using fast multidetector CT, we obtained images of the upper airway in the waking and sleep states. RESULTS: Upper airway narrowing during sleep was significantly greater at the retropalatal level than at the retroglossal level in the OSA group (p < 0.001) and in the control group (p < 0.05). The retropalatal airway volume was smaller in the OSA group than in the control group during wakefulness (p < 0.05) and decreased significantly from wakefulness to sleep only among the OSA group subjects. Retropalatal pharyngeal narrowing was attributed to reductions in the anteroposterior diameter (p = 0.001) and lateral diameter (p = 0.006), which correlated with an increase in lateral pharyngeal wall volume (p = 0.001) and posterior displacement of the tongue (p = 0.001), respectively. Retroglossal pharyngeal narrowing during sleep did not occur in the OSA group subjects. CONCLUSIONS: In patients with OSA, upper airway narrowing during sleep occurs predominantly at the retropalatal level, affecting the anteroposterior and lateral dimensions, being associated with lateral pharyngeal wall enlargement and posterior tongue displacement.
Assuntos
Tomografia Computadorizada Multidetectores/métodos , Doenças Faríngeas/diagnóstico por imagem , Doenças Respiratórias/diagnóstico por imagem , Apneia Obstrutiva do Sono/diagnóstico por imagem , Língua/diagnóstico por imagem , Adulto , Idoso , Estudos de Casos e Controles , Humanos , Masculino , Pessoa de Meia-Idade , Palato/diagnóstico por imagem , Palato/patologia , Palato/fisiopatologia , Doenças Faríngeas/patologia , Doenças Faríngeas/fisiopatologia , Faringe/diagnóstico por imagem , Faringe/patologia , Faringe/fisiopatologia , Polissonografia , Valores de Referência , Doenças Respiratórias/patologia , Doenças Respiratórias/fisiopatologia , Apneia Obstrutiva do Sono/patologia , Apneia Obstrutiva do Sono/fisiopatologia , Língua/patologia , Língua/fisiopatologia , Vigília/fisiologiaRESUMO
Introduction: The Chronic Respiratory Disease Questionnaire Self-Administered Standardized (CRQ-SAS) format is used to assess health-related quality of life in different languages and adult populations, but it has not been validated in adolescents. This study analyzes the psychometric properties of the CRQ-SAS in a sample of adolescent patients with chronic respiratory disease and correlates them to anxiety and depression. Method: In relation to the CRQ-SAS psychometric properties, exploratory and confirmatory factor analyses were done to assess the instrument's reliability and validity. Correlations and multiple linear regressions with the Hospital Anxiety and Depression Scale were done to assess the relation with anxiety and depression. The mean difference was estimated based on sociodemographic outcome measures. Results: The CRQ-SAS was administered to 280 children and adolescents with chronic respiratory disease aged 9-18 years (mean=12.02), with a similar male-female distribution. The original 4-factor structure was maintained; 3 items were removed from the original scale and a new 17-item version was obtained. This showed adequate psychometric properties and discriminant validity. The dyspnea and emotional functioning domains better predicted anxiety and depression. Lastly, scales were obtained for the interpretation of health-related quality of life scores. Conclusions: This questionnaire, which has been previously used in the adult population, may be an adequate instrument to assess health-related quality of life in adolescent patients with chronic respiratory disease.
Introducción. El Cuestionario de Enfermedad Respiratoria Crónica Autoadminsitrado (CRQ-SAS) es un instrumento utilizado para evaluar calidad de vida relacionada con la salud en diferentes idiomas y poblaciones adultas, aunque no en adolescentes. Este estudio analiza las propiedades psicométricas del CRQ-SAS en una muestra de pacientes adolescentes con enfermedad respiratoria crónica y las relaciona con la clínica ansioso-depresiva. Método. Para analizar propiedades psicométricas del CRQ-SAS, se realizaron análisis factoriales exploratorios y confirmatorios, para estudiar la fiabilidad y validez de la escala. Para evaluar las relaciones con la clínica ansioso-depresiva, se realizaron correlaciones y regresiones lineales múltiples con la Escala de Ansiedad y Depresión Hospitalaria. Se calcularon diferencias de medias en función de variables sociodemográficas. Resultados. El CRQ-SAS fue administrado en 280 niños y adolescentes con enfermedad respiratoria crónica de edades comprendidas entre 9 y 18 años (Media= 12,02) con una distribución similar entre varones y mujeres. Se mantuvo la estructura original de cuatro factores, se eliminaron 3 ítems de la escala original, y se obtuvo una nueva versión de 17 ítems. Esta mostró adecuadas propiedades psicométricas y de validez discriminante. La disnea y la función emocional fueron las dimensiones que mejor predijeron la clínica ansioso-depresiva. Por último, se obtuvieron baremos para la interpretación de las puntuaciones en la calidad de vida relacionada con la salud. Conclusiones. Este cuestionario, utilizado anteriormente en población adulta, puede ser un adecuado instrumento para evaluar calidad de vida relacionada con la salud en pacientes adolescentes con enfermedad respiratoria crónica.
Assuntos
Qualidade de Vida , Doenças Respiratórias/psicologia , Inquéritos e Questionários , Adolescente , Ansiedade , Criança , Doença Crônica , Estudos Transversais , Depressão/epidemiologia , Dispneia/epidemiologia , Feminino , Humanos , Idioma , Masculino , Psicometria , Reprodutibilidade dos Testes , Doenças Respiratórias/fisiopatologiaRESUMO
Hospitalizations due to respiratory diseases generate financial costs for the Health System in addition to social costs. Objective of this study was to develop and validate a fuzzy linguistic model for prediction of hospitalization due to respiratory diseases. We constructed a fuzzy model for prediction of hospitalizations due to pneumonia, bronchitis, bronchiolitis and asthma second exposure to fine particulate matter (PM2.5) in residents of Volta Redonda, RJ, in 2012. The model contains two inputs, PM2.5 and temperature, with three membership functions for each input, and an output with three membership functions for admissions, which were obtained from DATASUS. There were 752 hospitalizations in the period, the average concentration of PM2.5 was 17.1 µg/m3 (SD = 4.4). The model showed a good accuracy with PM2.5, the result was between 90% and 76.5% for lags 1, 2 and 3, a sensitivity of up to 95%. This study provides support for creating executable software with a low investment, along with the use of a portable instrument could allow number of hospital admission due to respiratory diseases and provide support to local health managers. Furthermore, the fuzzy model is very simple and involves low computational costs, an implementation making possible.
Assuntos
Lógica Fuzzy , Hospitalização/estatística & dados numéricos , Modelos Teóricos , Doenças Respiratórias/epidemiologia , Poluentes Atmosféricos/toxicidade , Poluição do Ar/efeitos adversos , Brasil/epidemiologia , Exposição Ambiental/efeitos adversos , Hospitalização/economia , Humanos , Material Particulado/toxicidade , Admissão do Paciente/estatística & dados numéricos , Reprodutibilidade dos Testes , Doenças Respiratórias/etiologia , Doenças Respiratórias/fisiopatologia , Sensibilidade e EspecificidadeRESUMO
Abstract Hospitalizations due to respiratory diseases generate financial costs for the Health System in addition to social costs. Objective of this study was to develop and validate a fuzzy linguistic model for prediction of hospitalization due to respiratory diseases. We constructed a fuzzy model for prediction of hospitalizations due to pneumonia, bronchitis, bronchiolitis and asthma second exposure to fine particulate matter (PM2.5) in residents of Volta Redonda, RJ, in 2012. The model contains two inputs, PM2.5 and temperature, with three membership functions for each input, and an output with three membership functions for admissions, which were obtained from DATASUS. There were 752 hospitalizations in the period, the average concentration of PM2.5 was 17.1 µg/m3 (SD = 4.4). The model showed a good accuracy with PM2.5, the result was between 90% and 76.5% for lags 1, 2 and 3, a sensitivity of up to 95%. This study provides support for creating executable software with a low investment, along with the use of a portable instrument could allow number of hospital admission due to respiratory diseases and provide support to local health managers. Furthermore, the fuzzy model is very simple and involves low computational costs, an implementation making possible.
Resumo Internações por doenças respiratórias geram custos financeiros para o Sistema de Saúde além de custos sociais. O objetivo deste estudo foi elaborar e validar um modelo linguístico "fuzzy" para previsão do número de internações por doenças respiratórias. Foi construído um modelo "fuzzy" para predição de internações por pneumonias, bronquite, bronquiolite e asma segundo exposição ao material particulado fino (PM2,5) em residentes de Volta Redonda, RJ, em 2012. O modelo contém duas entradas PM2,5 e temperatura, com três funções de pertinência para cada entrada, e uma saída com três funções de pertinência para internações, que foram obtidas do DATASUS. Foram 752 internações no período, a concentração média do PM2,5 foi 17,1 µg/m3 (dp = 4,4). O modelo mostrou uma boa acurácia com PM2,5, o resultado foi entre 90% e 76,5% para os lags 1, 2 e 3, com sensibilidade de até 95%. Este estudo fornece subsídios para a criação de programa executável, que não exige um grande investimento, juntamente com o uso de um instrumento portátil pode permitir uma estimativa do número de internações e prestar apoio aos gestores municipais de saúde. Além disso, o modelo "fuzzy" é muito simples e implica em baixas despesas computacionais, tornando possível uma implementação.
Assuntos
Humanos , Doenças Respiratórias/epidemiologia , Lógica Fuzzy , Hospitalização/estatística & dados numéricos , Modelos Teóricos , Admissão do Paciente/estatística & dados numéricos , Doenças Respiratórias/etiologia , Doenças Respiratórias/fisiopatologia , Brasil/epidemiologia , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Poluentes Atmosféricos/toxicidade , Poluição do Ar/efeitos adversos , Exposição Ambiental/efeitos adversos , Material Particulado/toxicidade , Hospitalização/economiaRESUMO
Introducción: La enfermedad respiratoria crónica determina alta morbimortalidad y frecuencia de comorbilidades cardiometabólicas. Evaluamos la asociación entre flujo espiratorio máximo (FEM) y algunas condiciones cardiometabólicas en adultos de una zona semirural, en la medición basal de la cohorte MAUCO (MAUle COhort). Material y Método: Estudio transversal (3.465 adultos, 40-74 años). Se midió el flujo espiratorio máximo (FEM) (mini-Wright, estándar ATS) utilizándose valores de Gregg y Nunn (FEM deteriorado ≤ 80% del teórico). Se obtuvo autorreporte/mediciones de hipertensión arterial (HTA), enfermedad cerebrovascular (ECV), infarto al miocardio (IAM), diabetes mellitus 2 (DM2), presión arterial, glicemia, colesterol, peso y talla. Actividad física y tabaquismo se evaluaron por encuesta, previa aprobación Ética. Se calcularon medidas de asociación, prevalencia y Odds Ratio (OR). Resultados: Muestra de 63,9% de mujeres edad media 55 (± 9) años, escolaridad media 9 (± 4) años. 84,7% tuvo exceso de peso, 81,5% inactividad física 29,4% fumadores actuales. Prevalencia de FEM bajo: 50,6% (IC 95% 48,9-52,3). El autorreporte fue: ACV 2,2% IAM 3,3, sospecha de hipertensión 24% y DM2 2,7%. Los OR crudos fueron significativos en mujeres que autorreportaron HTA, ECV, IAM y autorreporte/sospecha de DM2, y en hombres con autorreporte de ECV, sospecha de DM2 y autorreporte/sospecha de HTA. La asociación se mantuvo post-ajuste en mujeres para autorreporte de IAM y deterioro moderado (OR = 2,49) y severo del FEM (OR = 2,60) y en hombres para sospecha de DM2 y deterioro leve (OR = 5,24) y severo del FEM (OR = 6,19). Conclusiones: FEM resultó significativamente asociado con las enfermedades cardiometabólicas seleccionadas, con efecto sexo- específico para IAM (mujeres) y sospecha de DM2 (hombres). Se constata alta prevalencia de FEM alterado, y de enfermedades cardiometabólicas crónicas en la población estudiada.
Introduction: Chronic respiratory diseases determine high morbimortality and cardiometabolic comorbidities. We evaluated the association between peak expiratory flow (PEF) and cardiometabolic conditions in adults in a semi-rural area, in the baseline of MAUCO cohort (MAUle COhort). Material and Method: Cross-sectional study (3,465 adults, 40-74 years). Peak expiratory flow (PEF) (mini-Wright, ATS standard) was measured (Gregg & Nunn; impaired PEF ≤ 80% predicted). Self-reported/measured hypertension (HT), cerebrovascular disease (CVD), myocardial infarction (AMI), diabetes mellitus 2 (DM2), blood pressure, glycemia, cholesterol, weight and height were obtained. Physical activity and smoking were surveyed, after Ethical approval. Association's measures, prevalence and Odds Ratio (OR) were calculated. Results: Sample of 63.9% of women, mean age 55 (± 9) years, schooling 9 (± 4) years. 84.7% had overweight, 81.5%physical inactivity 29.4% smokers. Low PEF: 50.6% (48.9-52.3). Self-reported was: CVD 2.2% AMI 3.3%, suspicion of hypertension 24% and DM2 2.7%. Crude OR`s were significant for women by self-reported hypertension, stroke, AMI and self-reported/suspicion DM2; in men for self-reported CVD, suspected DM2 and self-reported/suspected hypertension. The association remained post-adjusted in women self-reported AMI -moderate deterioration (OR = 2.49) and severe PEF (OR = 2.60) and in men suspected DM2 and mild (OR = 5.24) and severe deteriorated PEF (OR = 6.19). Conclusions: PEF was significantly associated with cardiometabolic diseases; sex- specific findings for AMI (women) and suspicion of DM2 (men). High prevalence of altered PEF and chronic cardiometabolic diseases were detected among the studied population.
Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Doenças Respiratórias/epidemiologia , Doenças Cardiovasculares/epidemiologia , Fluxo Expiratório Máximo/fisiologia , Doenças Metabólicas/epidemiologia , Doenças Respiratórias/fisiopatologia , Doenças Cardiovasculares/fisiopatologia , Índice de Massa Corporal , Comorbidade , Chile/epidemiologia , Prevalência , Estudos Transversais , Fatores de Risco , Análise de Variância , Distribuição por Sexo , Diabetes Mellitus Tipo 2 , Dislipidemias , Hipertensão , Doenças Metabólicas/fisiopatologia , Infarto do MiocárdioRESUMO
Non-obstructed ever-smokers, with or without symptoms, have generated a great deal of information recently, but few reviews. Even individuals with normal spirometry can present changes in sputum with inflammatory biomarkers (cellular and molecular) and airways and parenchyma with remodeling; when symptomatic (cough, sputum, wheezing, and dyspnea) exacerbations are frequent affecting the individuals' quality of life, there is an increased use of health resources: more medication, emergency visits, and hospital admissions. Non-obstructed smokers may have exercise limitations, increased lung volumes, low diffusion capacity, air entrapment, peripheral airways obstruction, elevated airways resistance, and abnormal multiple breath nitrogen washout, as well as abnormalities in computed tomography studies, such as airway wall thickening, emphysema, or interstitial lung abnormalities. Quitting smoking comprises a first, inexpensive, and often abandoned intervention to arrest respiratory impairment. It is controversial whether or not this population should be treated with other medications. Further studies should be conducted to elucidate the consequences of follow-up and prognosis in this clinical entity.
Assuntos
Doenças Respiratórias/etiologia , Fumantes , Fumar/efeitos adversos , Humanos , Prognóstico , Qualidade de Vida , Doenças Respiratórias/diagnóstico , Doenças Respiratórias/fisiopatologia , Abandono do Hábito de Fumar/métodos , EspirometriaRESUMO
Electronic cigarettes, handheld devices that generate an aerosol that may contain nicotine by heating a solution or e-liquid, have been increasingly used especially in the young population. The aerosol's composition is determined by temperature, and by the substances contained in the heated liquid: glycerin, propylene glycol, nicotine in variable concentrations, flavoring agents, and other non-nicotine compounds. >80 compounds (including known toxics, e.g., formaldehyde, acetaldehyde, metallic nanoparticles, and acrolein) have been found in e-liquid and aerosols. Airway irritation, mucus hypersecretion, and inflammatory response, including systemic changes, have been observed after the exposure to e-cigarettes, leading to an increase in respiratory symptoms and changes in respiratory function and the host defense mechanisms. E-cigarette has been linked with an increase of symptoms in individuals with asthma, cystic fibrosis, and chronic obstructive pulmonary disease. One of the major concerns in public health is the rise in e-cigarette experimentation among never-smokers, especially children and adolescents, which leads to nicotine addiction and increases the chances of becoming with time a conventional smoker. There is an urgent need to regulate e-cigarettes and electronic nicotine delivery systems, at least with the same restrictions to those applied to tobacco products, and not to consider them as harmless products.
Assuntos
Sistemas Eletrônicos de Liberação de Nicotina/métodos , Nicotina/administração & dosagem , Vaping/efeitos adversos , Adolescente , Aerossóis , Criança , Humanos , Nicotina/efeitos adversos , Saúde Pública , Doenças Respiratórias/epidemiologia , Doenças Respiratórias/etiologia , Doenças Respiratórias/fisiopatologia , Vaping/epidemiologiaRESUMO
Abstract Electronic cigarettes, handheld devices that generate an aerosol that may contain nicotine by heating a solution or e-liquid, have been increasingly used especially in the young population. The aerosol's composition is determined by temperature, and by the substances contained in the heated liquid: glycerin, propylene glycol, nicotine in variable concentrations, flavoring agents, and other non-nicotine compounds. >80 compounds (including known toxics, e.g., formaldehyde, acetaldehyde, metallic nanoparticles, and acrolein) have been found in e-liquid and aerosols. Airway irritation, mucus hypersecretion, and inflammatory response, including systemic changes, have been observed after the exposure to e-cigarettes, leading to an increase in respiratory symptoms and changes in respiratory function and the host defense mechanisms. E-cigarette has been linked with an increase of symptoms in individuals with asthma, cystic fibrosis, and chronic obstructive pulmonary disease. One of the major concerns in public health is the rise in e-cigarette experimentation among never-smokers, especially children and adolescents, which leads to nicotine addiction and increases the chances of becoming with time a conventional smoker. There is an urgent need to regulate e-cigarettes and electronic nicotine delivery systems, at least with the same restrictions to those applied to tobacco products, and not to consider them as harmless products.
Assuntos
Humanos , Criança , Adolescente , Sistemas Eletrônicos de Liberação de Nicotina/métodos , Vaping/efeitos adversos , Nicotina/administração & dosagem , Doenças Respiratórias/etiologia , Doenças Respiratórias/fisiopatologia , Doenças Respiratórias/epidemiologia , Saúde Pública , Aerossóis , Vaping/epidemiologia , Nicotina/efeitos adversosRESUMO
Abstract Non-obstructed ever-smokers, with or without symptoms, have generated a great deal of information recently, but few reviews. Even individuals with normal spirometry can present changes in sputum with inflammatory biomarkers (cellular and molecular) and airways and parenchyma with remodeling; when symptomatic (cough, sputum, wheezing, and dyspnea) exacerbations are frequent affecting the individuals quality of life, there is an increased use of health resources: more medication, emergency visits, and hospital admissions. Non-obstructed smokers may have exercise limitations, increased lung volumes, low diffusion capacity, air entrapment, peripheral airways obstruction, elevated airways resistance, and abnormal multiple breath nitrogen washout, as well as abnormalities in computed tomography studies, such as airway wall thickening, emphysema, or interstitial lung abnormalities. Quitting smoking comprises a first, inexpensive, and often abandoned intervention to arrest respiratory impairment. It is controversial whether or not this population should be treated with other medications. Further studies should be conducted to elucidate the consequences of follow-up and prognosis in this clinical entity.